Chaim Sheba Medical Center - pt

Ramat Gan

0 studies enrolling now · 3 studies all time

What they study most

Head and Neck Cancer, Systemic Lupus Erythematosus

Studies at this site

• The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE) — Running, not enrolling
• Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION) — Stopped early
• The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW) — Completed